| 273.91 3.82 (1.41%) | 07-26 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 324.37 |
1-year : | 378.87 |
| Resists | First : | 277.72 |
Second : | 324.37 |
| Pivot price | 251.89 |
|||
| Supports | First : | 253.14 |
Second : | 237.94 |
| MAs | MA(5) : | 264.96 |
MA(20) : | 249.62 |
| MA(100) : | 251.98 |
MA(250) : | 235.53 |
|
| MACD | MACD : | 3.7 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 84.5 |
D(3) : | 79.9 |
| RSI | RSI(14): 70.7 |
|||
| 52-week | High : | 277.72 | Low : | 182.08 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ DHR ] has closed It is unclear right now based on current values. 133.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 277.89 - 278.71 | 278.71 - 279.63 |
| Low: | 268.88 - 269.88 | 269.88 - 271.01 |
| Close: | 272.14 - 273.65 | 273.65 - 275.35 |
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Fri, 26 Jul 2024
Danaher executive sells over $2.6 million in company stock - Investing.com India
Fri, 26 Jul 2024
Danaher Corporation (DHR): Hedge Funds Are Bullish on This Scientific Instruments Stock Right Now - Insider Monkey
Fri, 26 Jul 2024
Top Stock Reports for Costco, Danaher & ServiceNow - Yahoo Finance
Fri, 26 Jul 2024
Leerink Partnrs Comments on Danaher Co.'s FY2024 Earnings (NYSE:DHR) - MarketBeat
Fri, 26 Jul 2024
Danaher (NYSE:DHR) Announces Earnings Results - Defense World
Fri, 26 Jul 2024
Acadian Asset Management LLC Sells 1,003 Shares of Danaher Co. (NYSE:DHR) - Defense World
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Diagnostics & Research
|
|
| Shares Out | 741 (M) |
| Shares Float | 660 (M) |
| Held by Insiders | 10.7 (%) |
| Held by Institutions | 81.5 (%) |
| Shares Short | 8,610 (K) |
| Shares Short P.Month | 7,120 (K) |
| EPS | 5.46 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 72.16 |
| Profit Margin | 18.5 % |
| Operating Margin | 23 % |
| Return on Assets (ttm) | 3.8 % |
| Return on Equity (ttm) | 7.7 % |
| Qtrly Rev. Growth | -2.6 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 32.05 |
| EBITDA (p.s.) | 10.01 |
| Qtrly Earnings Growth | -25.2 % |
| Operating Cash Flow | 6,960 (M) |
| Levered Free Cash Flow | 4,860 (M) |
| PE Ratio | 50.16 |
| PEG Ratio | 4.2 |
| Price to Book value | 3.79 |
| Price to Sales | 8.54 |
| Price to Cash Flow | 29.14 |
| Dividend | 0.27 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|